Prior to joining Varian, Hutchinson most recently served as VP and advisor to the chairman and CEO at Stryker. He also previously served as general counsel, VP and chief legal officer at Stryker where is he oversaw the global legal and compliance organization and the corporate secretary function.
Facchini joined the company as chief medical officer in 2019. In early 2020, he transitioned to interim leader of the interventional solutions to business. He is a board certified interventional radiologist with clinical appointment with VIR Chicago.
“Varian is propelled by a bold vision for the future of cancer care and a commitment to delivering innovative solutions for our customers and their patients,” president and CEO Dow Wilson said in a news release. “Both Michael and Frank are highly esteemed experts in their disciplines, with outstanding credentials and proven track records. We are confident that their leadership will be a tremendous asset as we continue to work toward a world without fear of cancer.”